# A Study of Combination of Anti-PD1 Antibody-activated TILs and Chemotherapy in Colorectal Cancer

> **NCT03904537** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Sun Yat-sen University** · enrollment: 20 (estimated)

## Conditions studied

- Colorectal Cancer Stage III

## Interventions

- **BIOLOGICAL:** anti-PD-1 antibody-activated TILs

## Key facts

- **NCT ID:** NCT03904537
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-02-19
- **Primary completion:** 2019-12-31
- **Final completion:** 2021-12-31
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2019-04-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03904537

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03904537, "A Study of Combination of Anti-PD1 Antibody-activated TILs and Chemotherapy in Colorectal Cancer". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03904537. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*